drugset / Trial / NCT02249351
Efficacy and Safety of Talsaclidine (Free Base) in Patients With Mild to Moderate Dementia of Alzheimer Type
RandomizedParallel-groupDouble-blindTreatment
Summary
Study to assess symptomatic efficacy, safety and tolerability of talsaclidine in patients with mild to moderate dementia of Alzheimer type
Timeline
- Start
- 1999-12
- Primary completion
- 2000-05
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Talsaclidine | Small molecule | 48 mg | Oral |
| Subject | Talsaclidine | Small molecule | 60 mg | Oral |